MicroRNA‑663b mediates TAM resistance in breast cancer by modulating TP73 expression

Molecular Medicine Reports
Hua JiangRenbin Liu

Abstract

Breast cancer is the second leading cause of cancer‑associated mortalities in women. Tamoxifen (TAM) is an endocrine therapy commonly used in the treatment of patients with breast cancer expressing estrogen receptor α. However, treatment often ends in failure due to the emergence of drug resistance. MicroRNAs (miRNAs), a family of small non‑coding RNAs, serve critical roles in the regulation of gene expression and cell events. To date, whether miRNA‑663b could mediate TAM resistance in breast cancer remains unknown. Therefore, the aim of the present study was to investigate the role of miRNA‑663b in TAM resistance in breast cancer. The results demonstrated that miRNA‑663b was upregulated in breast cancer with TAM resistance. Tumor protein 73 (TP73) was a direct target of miRNA‑663b, and was negatively regulated by miRNA‑663b in MCF‑7 cells. Furthermore, it was identified that downregulation of miRNA‑663b inhibited cell proliferation ability and promoted cell apoptosis, resulting in enhanced TAM sensitivity. In addition, these findings suggested that TP73 silencing may have eliminated the effects of miRNA‑663b inhibitor on breast cancer cells. In conclusion, the present study verified a novel molecular link between miRNA‑663b an...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 23, 2002·Cell Death and Differentiation·I CascianoM Romani
Mar 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Carolina GutierrezMitch Dowsett
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Mar 3, 2006·Genes & Development·Marco Antonio Valencia-SanchezRoy Parker
Aug 3, 2007·The Journal of Clinical Investigation·George A Calin, Carlo M Croce
Jan 24, 2009·Nature Reviews. Molecular Cell Biology·V Narry KimMikiko C Siomi
Dec 22, 2010·Molecular Cancer·Diana M CittellyFrank E Jones
Feb 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Oct 1, 2013·The Breast : Official Journal of the European Society of Mastology·James N Ingle
Dec 19, 2013·Current Opinion in Obstetrics & Gynecology·Nicole Williams, Lyndsay N Harris
May 30, 2017·Acta Pharmacologica Sinica·Ya-Ling WangHai-Yan Hu
Jun 3, 2017·EMBO Molecular Medicine·Marilena V Iorio, Carlo M Croce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.